Sign inJoin waitlistJoin the waitlist

Sean McBride

Vice Chair for Clinical Strategy, Operations, and Physician Practice · New York Presbyterian Hospital

Credentials: · · · · ·

History

Operations · New York Presbyterian Hospital
Present
Marshall University
Present

Radiation Oncology
Mass General Brigham
2009–2013
Preliminary or Transitional Year
2008–2009
Harvard T.H. Chan School of Public Health
Yale Univ Sch of Med
2004–2008

Research

Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management
The Journal of Urology · 2022 · 411 citations
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma
Journal of Clinical Oncology · 2021 · First of 19 authors · 356 citations
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up
The Journal of Urology · 2022 · 226 citations

NL
Nancy Lee
98 papers
Nadeem Riaz
82 papers · 2 as a resident
ES
Eric Sherman
56 papers
CT
Chiaojung Tsai
48 papers · 1 as a resident
Richard Wong
47 papers
YY
Yao Yu
46 papers · 4 as a resident
MK
Marisa Kollmeier
38 papers
Michael Zelefsky
36 papers
DG
Daphna Gelblum
35 papers
Ian Ganly
34 papers
Kaveh Zakeri
33 papers
LD
Lara Dunn
33 papers · 1 as a fellow

Clinical trials

A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma
Principal investigator · Recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2024–2027
AASUR in High Risk Prostate Cancer
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2016–2026
Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2016–2021
Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2009–2026